The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI), on Tuesday.
Approximately 16 billion vaccine doses, worth USD 141 billion, were supplied in 2021, almost three times the 2019 market volume (5.8 billion) and nearly three-and-a-half times the 2019 market value (USD 38 billion). The increase was primarily driven by COVID-19 vaccines, showing the incredible potential of how vaccine manufacturing can be scaled up in response to health needs.
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to COVID-19 pandemic, said SII CEO Adar Poonawala on Friday.
New Delhi [India], July 12 (ANI): India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India (DCGI) approval for market authorisation. This vaccine will be manufactured by the Serum Institute of India (SII).
Houston [US], June 22 (ANI): A recent study by researchers of UTHealth Houston discovered that using mushroom extract daily helps the immune system in clearing human papillomavirus (HPV) infections.
New Delhi [India], June 20 (ANI/GPRC): Real Estate Entrepreneur and Social Activist Nidarshana Gowani organized a blood donation camp at Kamala Mills Compound, Lower Parel on the World Blood Donor Day. The camp had many people visiting the camp to donate their blood and save lives.
New Delhi [India], March 17 (ANI/PNN): Nidarshana Gowani and her trust Ankibai Ghamandiram Gowani Trust organized a free HPV vaccination drive for girls and women at R A Poddar Hospital in Mumbai on the National Vaccination Day.
New Delhi [India], March 9 (ANI/PNN): Oral cancer in India is on the rise, with more than 1 lakh new cases in 2018, according to the Global Cancer Observatory. The central challenge of most Oral Cancer forums is to focus on addressing this disease in India, which is the "Oral Cancer Capital of the World."
New Delhi [India], February 4 (ANI): Noting the increasing burden of cancer despite 30 per cent to 50 per cent of the cases being preventable, the World Health Organization today called on countries in South-East Asia Region to prioritize measures to reduce risk, detect and diagnose early and care for people suffering from the disease.
Washington [US], October 27 (ANI): University of California, Los Angeles researchers add monoclonal antibody to target oropharyngeal cancer in HPV-positive patients with KRAS gene variant.